230 related articles for article (PubMed ID: 2384100)
1. Biodistribution in normal mice of an 111In-labelled prostatic acid phosphatase-specific antibody and its F(ab')2 fragments derivatized site-specifically or via bicyclic diethylenetriaminepentaacetic acid anhydride.
Perälä M; Vihko P; Södervall M; Heikkilä J; Vihko R
Eur J Nucl Med; 1990; 16(8-10):621-6. PubMed ID: 2384100
[TBL] [Abstract][Full Text] [Related]
2. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
[TBL] [Abstract][Full Text] [Related]
3. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
Peräalä-Heape M; Vihko P; Vihko R
Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
[TBL] [Abstract][Full Text] [Related]
4. Labeling monoclonal antibodies and F(ab')2 fragments with (111In) indium using cyclic DTPA anhydride and their in vivo behavior in mice bearing human tumor xenografts.
Powe J; Pak KY; Paik CH; Steplewski Z; Ebbert MA; Herlyn D; Ernst C; Alavi A; Eckelman WC; Reba RC
Cancer Drug Deliv; 1984; 1(2):125-35. PubMed ID: 6544629
[TBL] [Abstract][Full Text] [Related]
5. Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
Perälä-Heape M; Vihko P; Laine A; Heikkilä J; Vihko R
Eur J Nucl Med; 1991; 18(5):339-45. PubMed ID: 1936042
[TBL] [Abstract][Full Text] [Related]
6. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
Kurkela R; Vuolas L; Vihko P
J Immunol Methods; 1988 Jun; 110(2):229-36. PubMed ID: 3132507
[TBL] [Abstract][Full Text] [Related]
7. Radiolabelling of monoclonal antibodies: optimization of conjugation of DTPA to F(ab')2-fragments and a novel measurement of the degree of conjugation using Eu(III)-labelling.
Hartikka M; Vihko P; Södervall M; Hakalahti L; Torniainen P; Vihko R
Eur J Nucl Med; 1989; 15(3):157-61. PubMed ID: 2469581
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
Khawli LA; Alauddin MM; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
11. Effect of DTPA to antibody ratio on chemical, immunological and biological properties of the 111In-labelled F(ab')2 fragment of the monoclonal antibody 431/31.
Kuhlmann L; Steinsträsser A
Int J Rad Appl Instrum B; 1988; 15(6):617-27. PubMed ID: 3251897
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O
Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218
[TBL] [Abstract][Full Text] [Related]
13. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
[TBL] [Abstract][Full Text] [Related]
14. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
Quadri SM; Lai J; Mohammadpour H; Vriesendorp HM; Williams JR
J Nucl Med; 1993 Dec; 34(12):2152-9. PubMed ID: 8254403
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
[TBL] [Abstract][Full Text] [Related]
16. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
Slinkin MA; Curtet C; Faivre-Chauvet A; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
